CD8A and myeloid sarcoma: HLA-E restricted CD8+ T-cells in patients with MS appeared phenotypically different from healthy controls; however these T-cells were selected based on the expression of NKG2C and thus may reflect only a small subset of HLA-E restricted T-cells [60].